Tapewire

Nasdaq · USD

NSPR

InspireMD, Inc.

Export transactions ↓
Tapewire entity
7318
SEC CIK
0001433607
Parsed reports
164

Last 12 months

Inside the activity.

18 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202540
Jan 202609
Feb 202602
Mar 202600
Apr 202600
May 2026131
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 07, 2025 Filed Jan 10, 2025 21:30 UTC GrantCommon Stock 32,491 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001726 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,533

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Shore CraigCFO and CAO
GrantOptions to purchase common stock (right to buy) · Derivative 106,218 $0.00 Strike: $2.71 $0.00
Disclosure

SEC source: 0001493152-25-001730 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 417,706

Underlying: Common Stock · 106,218 shares

Expires 2035-01-07

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
January 07, 2025 Filed Jan 10, 2025 21:30 UTC
Shore CraigCFO and CAO
GrantCommon Stock 232,616 $0.00 $0.00
Disclosure

SEC source: 0001493152-25-001730 · ownership.xml · nonDerivative · entry 1

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,112,460

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC OtherSeries H Warrant (right to buy) · Derivative 61,249 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-24-025340 · ownership.xml · derivative · entry 3

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 61,249 shares

Expires 2024-06-26

F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 24, 2024 Filed Jun 27, 2024 01:30 UTC OtherCommon Stock 61,249 $1.38 $84,688.99
Disclosure

SEC source: 0001493152-24-025340 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 183,746

F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 22:50 UTC
Stuka PaulDirector
OtherSeries H Warrant (right to buy) · Derivative 87,500 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-24-023222 · ownership.xml · derivative · entry 3

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 87,500 shares

Expires 2024-06-26

F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
June 05, 2024 Filed Jun 7, 2024 22:50 UTC
Stuka PaulDirector
OtherCommon Stock 87,500 $1.38 $120,986.25
Disclosure

SEC source: 0001493152-24-023222 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 336,034

F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Read SEC document
May 28, 2024 Filed May 30, 2024 21:20 UTC OtherSeries H Warrant (right to buy) · Derivative 30,625 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-24-022012 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,625 shares

Expires 2024-06-26

Read SEC document
May 28, 2024 Filed May 30, 2024 21:20 UTC OtherCommon Stock 30,625 $1.38 $42,345.19
Disclosure

SEC source: 0001493152-24-022012 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,788

Read SEC document
May 28, 2024 Filed Jun 25, 2024 22:14 UTC OtherSeries H Warrant (right to buy) · Derivative 30,625 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-24-025143 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,625 shares

Expires 2024-06-26

Read SEC document
May 28, 2024 Filed Jun 25, 2024 22:14 UTC OtherCommon Stock 30,625 $1.38 $42,345.19
Disclosure

SEC source: 0001493152-24-025143 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 326,652

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC GrantOptions to purchase common stock (right to buy) · Derivative 11,098 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003771 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,907

Underlying: Common Stock · 11,098 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC GrantCommon Stock 29,032 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003771 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 471,163

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:52 UTC GrantOptions to purchase common stock (right to buy) · Derivative 11,098 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003772 · ownership.xml · derivative · entry 2

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,109

Underlying: Common Stock · 11,098 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 16:52 UTC GrantCommon Stock 29,032 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003772 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,040

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Slosman MarvinDirector · CEO and President
GrantOptions to purchase common stock (right to buy) · Derivative 215,405 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003773 · ownership.xml · derivative · entry 2

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 682,811

Underlying: Common Stock · 215,405 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Slosman MarvinDirector · CEO and President
GrantRestricted Stock Units 563,499 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003773 · ownership.xml · nonDerivative · entry 1

Slosman Marvin · CIK 0001796908 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,852,119

F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:53 UTC GrantOptions to purchase common stock (right to buy) · Derivative 11,098 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003778 · ownership.xml · derivative · entry 2

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,111

Underlying: Common Stock · 11,098 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:53 UTC GrantCommon Stock 29,032 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003778 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 296,075

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:53 UTC
Verta PatrickEVP Clinical/Medical Affairs
GrantOptions to purchase common stock (right to buy) · Derivative 32,768 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003775 · ownership.xml · derivative · entry 2

Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,348

Underlying: Common Stock · 32,768 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:53 UTC
Verta PatrickEVP Clinical/Medical Affairs
GrantCommon Stock 85,720 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003775 · ownership.xml · nonDerivative · entry 1

Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,460

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Gleason Shane ThomasChief Commercial Officer
GrantOptions to purchase common stock (right to buy) · Derivative 91,218 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003777 · ownership.xml · derivative · entry 2

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 183,128

Underlying: Common Stock · 91,218 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Gleason Shane ThomasChief Commercial Officer
GrantCommon Stock 238,625 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003777 · ownership.xml · nonDerivative · entry 1

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 514,365

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Tommasoli AndreaChief Operating Officer
GrantOptions to purchase common stock (right to buy) · Derivative 91,218 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003769 · ownership.xml · derivative · entry 2

Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,699

Underlying: Common Stock · 91,218 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Tommasoli AndreaChief Operating Officer
GrantCommon Stock 238,625 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003769 · ownership.xml · nonDerivative · entry 1

Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 495,078

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Shore CraigCFO and CAO
GrantOptions to purchase common stock (right to buy) · Derivative 91,218 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003770 · ownership.xml · derivative · entry 2

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,488

Underlying: Common Stock · 91,218 shares

Expires 2034-01-23

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Shore CraigCFO and CAO
GrantCommon Stock 238,625 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003770 · ownership.xml · nonDerivative · entry 1

Shore Craig · CIK 0001517387 · CFO and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 879,844

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Stuka PaulDirector
GrantOptions to purchase common stock (right to buy) · Derivative 16,647 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003776 · ownership.xml · derivative · entry 3

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,875

Underlying: Common Stock · 16,647 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC
Stuka PaulDirector
GrantCommon Stock 43,548 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003776 · ownership.xml · nonDerivative · entry 1

Stuka Paul · CIK 0001528577 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,548

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC GrantOptions to purchase common stock (right to buy) · Derivative 11,098 $0.00 Strike: $3.14 $0.00
Disclosure

SEC source: 0001493152-24-003774 · ownership.xml · derivative · entry 3

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,114

Underlying: Common Stock · 11,098 shares

Expires 2034-01-23

F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.

Read SEC document
January 23, 2024 Filed Jan 25, 2024 21:52 UTC GrantCommon Stock 29,032 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-003774 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,042

F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Read SEC document
January 02, 2024 Filed Jan 11, 2024 21:15 UTC GrantCommon Stock 3,229 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-002065 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 442,131

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023.

Read SEC document
January 02, 2024 Filed Jan 11, 2024 16:15 UTC GrantCommon Stock 1,661 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-002066 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,008

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023.

Read SEC document
January 02, 2024 Filed Jan 11, 2024 21:15 UTC GrantCommon Stock 3,782 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-002067 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,010

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023.

Read SEC document
January 02, 2024 Filed Jan 11, 2024 21:15 UTC GrantCommon Stock 3,183 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-002064 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,043

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023.

Read SEC document
November 30, 2023 Filed Dec 4, 2023 21:15 UTC PurchaseCommon Stock 50,000 $2.53 $126,540.00
Disclosure

SEC source: 0001493152-23-043561 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 438,902

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.47 to $2.60, inclusive. The Reporting Person undertakes to provide to InspireMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:15 UTC GrantCommon Stock 2,652 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-035640 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,902

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 16:15 UTC GrantCommon Stock 1,364 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-035642 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,347

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:15 UTC GrantCommon Stock 2,614 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-035647 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,860

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023.

Read SEC document
October 02, 2023 Filed Oct 4, 2023 20:15 UTC GrantCommon Stock 3,106 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-035644 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,228

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
Gleason Shane ThomasChief Commercial Officer
GrantOptions to purchase common stock (right to buy) · Derivative 6,430 $0.00 Strike: $3.37 $0.00
Disclosure

SEC source: 0001493152-23-030663 · ownership.xml · derivative · entry 2

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,910

Underlying: Common Stock · 6,430 shares

Expires 2033-08-28

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.

Read SEC document
August 28, 2023 Filed Aug 30, 2023 20:15 UTC
Gleason Shane ThomasChief Commercial Officer
GrantCommon Stock 19,290 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-030663 · ownership.xml · nonDerivative · entry 1

Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,740

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 28, 2024, August 28, 2025 and August 28, 2026, subject to the Reporting Person's continued service.

Read SEC document
July 01, 2023 Filed Jul 5, 2023 20:38 UTC GrantCommon Stock 3,445 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-023455 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386,250

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 5, 2023 16:15 UTC GrantCommon Stock 1,772 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-023435 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,983

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 5, 2023 20:15 UTC GrantCommon Stock 3,396 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-023437 · ownership.xml · nonDerivative · entry 1

Kester Thomas J · CIK 0001299870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 261,246

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023.

Read SEC document
July 01, 2023 Filed Jul 5, 2023 20:15 UTC GrantCommon Stock 4,351 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-023436 · ownership.xml · nonDerivative · entry 1

BERMAN MICHAEL · CIK 0001186801 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,122

F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:15 UTC GrantOptions to purchase common stock (right to buy) · Derivative 49,750 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0001493152-23-018331 · ownership.xml · derivative · entry 2

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,809

Underlying: Common Stock · 49,750 shares

Expires 2033-05-17

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:15 UTC GrantCommon Stock 149,260 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-018331 · ownership.xml · nonDerivative · entry 1

ROUBIN GARY S · CIK 0001162533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,805

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.

Read SEC document
May 17, 2023 Filed May 19, 2023 16:15 UTC GrantOptions to purchase common stock (right to buy) · Derivative 49,750 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0001493152-23-018329 · ownership.xml · derivative · entry 2

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,011

Underlying: Common Stock · 49,750 shares

Expires 2033-05-17

F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.

Read SEC document
May 17, 2023 Filed May 19, 2023 16:15 UTC GrantCommon Stock 149,260 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-018329 · ownership.xml · nonDerivative · entry 1

Arnold Kathryn · CIK 0001861350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,211

F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.